大摩:维持illumina(ILMN.US)评级,由持股观望调整至持股观望评级,目标价由156.00美元调整至150.00美元。Illumina(ILMN.US)公司简介:Illumina,Inc.从事生命科学工具和集成系统的开发、制造和营销,用于大规模分析遗传变异和功能。它通过核心Illumina部门运营,为研究,临床和应用市场领域的客户提供服务,并采用各种基因组解决方案。该公司的产品包括仪器,...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.